Department of Medical Microbiology, Central South University, Changsha, 410078 Hunan, China.
Department of Obstetrics, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Hunan, China.
J Immunol Res. 2022 Apr 28;2022:8307280. doi: 10.1155/2022/8307280. eCollection 2022.
From our previous study, we obtained long noncoding RNA (lncRNA) STAT4-AS1, which is related to asthma through high-throughput screening. However, we could not determine the specific mechanism involved and in response to this. We further designed this study.
First, we found that lncRNA STAT4-AS1 was downregulated in T cells from patients with asthma when compared to healthy controls. Next, we confirmed that lncRNA STAT4-AS1 was significantly negatively correlated with T helper 17 (TH17) differentiation in vitro experiments. The decreases of STAT4-AS1 promoted TH17 differentiation, while the increases of STAT4-AS1 inhibited TH17 differentiation. Subsequently, through RNA pull-down, RNA-binding protein immunoprecipitation (RIP), and dual luciferase reporter assay, we found that STAT4-AS1 could inhibit the binding of retinoid-related orphan receptor-t (RORt) protein with an IL-17A promoter after binding with RORt protein. Fluorescence in situ hybridization (FISH) and nuclear-cytoplasmic separation assay showed that STAT4-AS1 is bonded to RORt in the cytoplasm, preventing RORt from entering the nucleus.
Overall, STAT4-AS1 directly targets RORt protein, inhibits the mutual binding of RORt and IL-17 gene promoter, and eventually inhibits TH17 differentiation. To this end, STAT4-AS1 as a potential target may confer applications in the clinical treatment and diagnosis of TH17-related diseases.
在我们之前的研究中,通过高通量筛选获得了与哮喘相关的长链非编码 RNA(lncRNA)STAT4-AS1,但我们无法确定其中涉及的具体机制。因此,我们进一步设计了这项研究。
首先,我们发现与健康对照组相比,哮喘患者的 T 细胞中 lncRNA STAT4-AS1 表达下调。其次,我们在体外实验中证实 lncRNA STAT4-AS1 与辅助性 T 细胞 17(TH17)分化呈显著负相关。降低 STAT4-AS1 可促进 TH17 分化,而增加 STAT4-AS1 则可抑制 TH17 分化。随后,通过 RNA 下拉、RNA 结合蛋白免疫沉淀(RIP)和双荧光素酶报告基因检测,我们发现 STAT4-AS1 可与 RORt 蛋白结合后抑制 RORt 蛋白与 IL-17A 启动子的结合。荧光原位杂交(FISH)和核质分离实验表明,STAT4-AS1 与 RORt 在细胞质中结合,阻止 RORt 进入细胞核。
综上所述,STAT4-AS1 可直接靶向 RORt 蛋白,抑制 RORt 与 IL-17 基因启动子的相互结合,从而最终抑制 TH17 分化。为此,STAT4-AS1 作为一种潜在的靶点,可能在 TH17 相关疾病的临床治疗和诊断中具有应用前景。